Specialty & Generic Drugs
1 article in this category
HealthcareRegulatorySpecialty & Generic Drugs
Regencell Bioscience (RGC) - July 3, 2026 - Decrease Prediction - Confidence 4/10
Bearish news sentiment (100% bearish) and severe regulatory overhang from DOJ investigation and class action lawsuit drive a decrease prediction for RGC, despite deeply oversold RSI.
RGC
Read more